Cite
HARVARD Citation
Skinningsrud, B. et al. (2010). A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis. Annals of the rheumatic diseases. 69 (8), pp. 1471-1474. [Online].